▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Xencor (NASDAQ: XNCR)

$7.67

(2.0%)

$0.15

Price as of May 22, 2025, 3:05 p.m. ET

Xencor Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
XNCR	-68.36%	-76.13%	-24.91%	-10%
S&P	+9.83%	+97.76%	+14.61%	+226%

Xencor Company Info

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

News & Analysis

Featured Article

Why Shares of Zencor Rose This Week

The clinical-stage biotech has seen its shares rise since a company presentation a few weeks ago.

Jim Halley | Jan 26, 2023

Featured Article

2 Top Cancer Treatment Stocks To Watch In July

These hidden gems have the potential to deliver significant returns to their shareholders over the long run.

Amar Khatri | Jul 14, 2020

3 Top Biotech Stocks to Buy Right Now

Sean Williams, Chuck Saletta, and Brian Feroldi | Jun 18, 2018

These drug stocks are prescribing some serious growth potential in the years to come.

3 Top Biotech Stocks to Buy in April

Todd Campbell, Sean Williams, and Brian Feroldi | Apr 4, 2018

Biotech stocks are falling, and that could be creating an opportunity to buy shares in these top companies.

3 Biotech Stocks to Buy in February

Sean Williams, Cory Renauer, and Brian Feroldi | Feb 16, 2017

These biotech stocks could put on a clinic in your investment portfolio.

3 Top Biotech Stocks to Buy in November

Brian Feroldi, Cory Renauer, and George Budwell | Nov 2, 2016

Looking for a biotech stock to buy this month? Our healthcare contributors believe that these three companies are compelling investments.

This Caused Xencor Inc.'s Stock to Jump 11.6% in August

Brian Feroldi | Sep 10, 2016

Shares rose in response to the company posting a surprise quarterly profit.

Why Xencor Inc's Shares Are Skyrocketing Today

Brian Feroldi | Jun 28, 2016

The signing of a lucrative partnership agreement with a pharma giant sends shares soaring.

Valuation

Earnings Transcripts

Xencor, inc (XNCR) Q3 2021 Earnings Call Transcript

XNCR earnings call for the period ending September 30, 2021.

Motley Fool Transcribers | Nov 8, 2021

Xencor, inc (XNCR) Q2 2021 Earnings Call Transcript

XNCR earnings call for the period ending June 30, 2021.

Motley Fool Transcribers | Aug 4, 2021

Xencor Inc (XNCR) Q1 2021 Earnings Call Transcript

XNCR earnings call for the period ending March 31, 2021.

Motley Fool Transcribers | May 6, 2021

Xencor Inc (XNCR) Q4 2020 Earnings Call Transcript

XNCR earnings call for the period ending December 31, 2020.

Motley Fool Transcribers | Feb 24, 2021

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services